Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24834545 | 0.97 | PAOX (0.31) | PAOX | |
| SCHEMBL24834424 | 0.97 | PAOX (0.31) | PAOX | |
| SCHEMBL25820457 | 0.90 | PAOX (0.39) | PAOXTHRATHRBDRD3HRH3 | |
| SCHEMBL25820446 | 0.86 | PAOX (0.38) | PAOXTHRATHRB | |
| SCHEMBL8738807 | 0.86 | PAOX (0.38) | PAOXTHRATHRB | |
| SCHEMBL19829897 | 0.86 | PAOX (0.37) | PAOXTHRATHRB | |
| SCHEMBL8739618 | 0.85 | PAOX (0.38) | PAOXTHRATHRBDRD3HRH3 | |
| SCHEMBL26872388 | 0.83 | ACHE (0.36) | PAOXTHRATHRBHRH3 | |
| SCHEMBL8739109 | 0.83 | THRA (0.40) | PAOXTHRATHRB | |
| SCHEMBL23762158 | 0.82 | PAOX (0.35) | PAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11697804-B2 | Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11697804-B2 | Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy | POLRMT, HDGF, PCNP | PAOX 1246/4885THRA 1193/4885THRB 1833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.